LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer
Authors
Keywords
-
Journal
Molecular Cancer
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-16
DOI
10.1186/s12943-022-01557-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer
- (2021) Shaocong Wu et al. Molecular Cancer
- The biology, function, and applications of exosomes in cancer
- (2021) Jinyi Liu et al. Acta Pharmaceutica Sinica B
- The role and application of small extracellular vesicles in gastric cancer
- (2021) Hao Wu et al. Molecular Cancer
- Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
- (2021) Ronan J. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation
- (2021) Youqian Wu et al. Nature Communications
- Lysine demethylase LSD1 delivered via small extracellular vesicles promotes gastric cancer cell stemness
- (2021) Li‐Juan Zhao et al. EMBO REPORTS
- An Update of Lysine Specific Demethylase 1 Inhibitor: A Patent Review (2016-2020)
- (2021) Yi-Chao Zheng et al. Recent Patents on Anti-Cancer Drug Discovery
- DUX-miR-344-ZMYM2-Mediated Activation of MERVL LTRs Induces a Totipotent 2C-like State
- (2020) Fan Yang et al. Cell Stem Cell
- Exploration of 5-cyano-6-phenylpyrimidin derivatives containing an 1,2,3-triazole moiety as potent FAD-based LSD1 inhibitors
- (2020) Liying Ma et al. Acta Pharmaceutica Sinica B
- Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma
- (2020) Cavan P Bailey et al. NEURO-ONCOLOGY
- TIMER2.0 for analysis of tumor-infiltrating immune cells
- (2020) Taiwen Li et al. NUCLEIC ACIDS RESEARCH
- Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective
- (2020) Xing-Jie Dai et al. JOURNAL OF MEDICINAL CHEMISTRY
- LSD1 deletion represses gastric cancer migration by upregulating a novel miR-142-5p target protein CD9
- (2020) Li-Juan Zhao et al. PHARMACOLOGICAL RESEARCH
- Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
- (2019) Xianjie Jiang et al. Molecular Cancer
- Exosomes in gastric cancer: roles, mechanisms, and applications
- (2019) Min Fu et al. Molecular Cancer
- Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
- (2019) Mauro Poggio et al. CELL
- Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer
- (2019) Abel H. Y. Tan et al. Frontiers in Immunology
- Arginine methylation‐dependent LSD1 stability promotes invasion and metastasis of breast cancer
- (2019) Jiwei Liu et al. EMBO REPORTS
- Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion
- (2018) Mario Mauthe et al. Autophagy
- Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma
- (2018) Yong Yu et al. CANCER CELL
- LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
- (2018) Wanqiang Sheng et al. CELL
- Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth
- (2018) Yi Yang et al. CELL RESEARCH
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
- (2018) Franz L. Ricklefs et al. Science Advances
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade
- (2018) Ye Qin et al. ONCOGENE
- FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD‐L1
- (2018) Lola Fashoyin‐Aje et al. ONCOLOGIST
- An Endothelial-to-Adipocyte Extracellular Vesicle Axis Governed by Metabolic State
- (2018) Clair Crewe et al. CELL
- HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity
- (2018) Huanbin Wang et al. Nature Chemical Biology
- Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
- (2017) Jinfang Zhang et al. NATURE
- CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
- (2017) Marian L. Burr et al. NATURE
- Discovery of [1,2,3]Triazolo[4,5-d]pyrimidine Derivatives as Novel LSD1 Inhibitors
- (2017) Zhong-Hua Li et al. ACS Medicinal Chemistry Letters
- The chromatin modifying complex CoREST/LSD1 negatively regulates notch pathway during cerebral cortex development
- (2016) Cecilia I. Lopez et al. Developmental Neurobiology
- A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC
- (2015) Helai P. Mohammad et al. CANCER CELL
- LSD1-Mediated Demethylation of H3K4me2 Is Required for the Transition from Late Progenitor to Differentiated Mouse Rod Photoreceptor
- (2015) Evgenya Y. Popova et al. MOLECULAR NEUROBIOLOGY
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
- (2013) Yi-Chao Zheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
- (2012) Tino Schenk et al. NATURE MEDICINE
- The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation
- (2008) Jing Wang et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started